← Back to catalogue

Nirflex Premounted Coronary Stent System

FDA PMA

Class III (US FDA PMA)

PMA P020040

by Medinol Ltd.

Identity

Trade Name
NIRFLEX PREMOUNTED STENT FDA PMA
Generic Name
STENT, CORONARY FDA PMA

Identifiers

PMA Number
P020040 FDA PMA
FDA Product Code
MAF FDA PMA

Classification

Device Class
Class III FDA PMA
Advisory Committee
Cardiovascular FDA PMA
FDA Decision
APWD FDA PMA

The Nirflex Premounted Coronary Stent System is a coronary stent designed to improve coronary luminal diameter in patients. It is indicated for use in patients with symptomatic ischemic disease caused by discrete de novo and restenotic lesions in native coronary arteries.

This device is intended for lesions with a length of 25 mm or less and in vessels with a reference diameter ranging from 2.5 mm to 4.0 mm. The system is manufactured by Medinol Ltd. and has received FDA PMA authorization under number P020040.

Frequently asked questions

What is the Nirflex Premounted Coronary Stent System used for?

The device is indicated for improving the coronary luminal diameter in patients suffering from symptomatic ischemic disease caused by discrete de novo and restenotic lesions in native coronary arteries.

What are the vessel size requirements for this stent?

The stent is designed for use in native coronary arteries that have a reference vessel diameter between 2.5 mm and 4.0 mm, with lesion lengths of 25 mm or less.

Who manufactures the Nirflex Coronary Stent?

The Nirflex Premounted Coronary Stent System is manufactured by Medinol Ltd., based in Tel Aviv.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_PMA

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Medinol Ltd.
FDA Applicant
Medinol, Ltd.

Sources (1)

  • FDA PMA P020040 24 fields · synced Sep 18, 2026